Recommended Cash Offer for Novae Group plc by Axis Capital Holdings Limited
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
Summary
- The boards of
AXIS Capital Holdings Limited (“AXIS”) andNovae Group plc (“Novae”) are pleased to announce that they have reached agreement on the terms of a recommended all cash acquisition of the entire issued and to be issued share capital of Novae by AXIS (or, at AXIS’s election, a whollyowned subsidiary of AXIS). - Under the terms of the Acquisition, each Novae Shareholder will be entitled to receive:
for each Novae Share:
- The consideration values the entire existing issued and to be issued share capital of Novae at approximately £467.6 million on the basis of a fully diluted share capital of 66,795,621 Novae Shares.
- The price of
700 pence per Novae Share represents:- a premium of approximately 20 per cent. to the closing mid-market price of
581 pence per Novae Share on4 July 2017 , being the last Business Day before the date of this Announcement; and - a premium of approximately 29 per cent. to the volume weighted average closing price per Novae Share for the one month period up to and including
4 July 2017 , being the last Business Day before the date of this Announcement.
- a premium of approximately 20 per cent. to the closing mid-market price of
- The consideration also implies a multiple of 1.5x Novae’s reported net tangible book value of £318.8 million as at
31 December 2016 (on a fully diluted basis). - The cash consideration payable under the Acquisition will be funded from AXIS’s existing cash resources or, if market conditions are favourable, from new borrowings.
- It is intended that the Acquisition will be implemented by way of a Courtsanctioned scheme of arrangement under Part 26 of the Companies Act, further details of which are contained in the full text of this Announcement.
- If, after the date of this Announcement, any dividend and/or other distribution and/or other return of capital is announced, declared or paid in respect of the Novae Shares, AXIS reserves the right to reduce the offer consideration by an amount up to the amount of such dividend and/or distribution and/or return of capital so announced, declared or paid, in which case any reference in this Announcement or the Scheme Document to the offer consideration for the Novae Shares will be deemed to be a reference to the offer consideration as so reduced. For further details, please refer to paragraph 15 of Part B of Appendix 1.
-
The Board of Novae , which has been so advised by Evercore as to the financial terms of the Acquisition, considers the terms of the Acquisition to be fair and reasonable. In providing their advice to theBoard of Novae , Evercore has taken into account the commercial assessments of theBoard of Novae . - Accordingly, the Novae Directors confirm that they intend unanimously to recommend that Novae Shareholders vote to approve the Scheme at the Court Meeting and vote in favour of the resolution to be proposed at the General Meeting, as those of them who hold Novae Shares in their own name or through a nominee have irrevocably undertaken to do in respect of all of their own beneficial holdings of Novae Shares.
- The terms of the Acquisition will be put to Novae Shareholders at the Court Meeting and the General Meeting (which is expected to immediately follow the Court Meeting). The Court Meeting and the General Meeting are required to enable Novae Shareholders to consider, and if thought fit, vote in favour of the resolution to approve the Scheme and its implementation. In order to become Effective, the Scheme must be approved by a majority in number of Scheme Shareholders, present and voting, whether in person or by proxy, representing 75 per cent. or more in nominal value of the Scheme Shares held by those Scheme Shareholders.
- The Acquisition is subject to a number of conditions, including the receipt of required regulatory, merger control and other necessary approvals, which are set out in Appendix 1 to this Announcement, certain other terms as are set out in this Announcement and to the full terms and conditions to be set out in the Scheme Document.
- AXIS is a
Bermuda -based provider of specialty lines insurance and reinsurance. AXIS is listed on theNYSE and has a market cap of c.$5.6 billion as at3 July 2017 (being the last US business day prior to the date of this Announcement). AXIS operates through locations inthe United States ,Europe ,Singapore , theMiddle East ,Canada andLatin America , with over 1,300 employees. As at31 March 2017 , AXIS had$6,230 million of total shareholders’ equity and$21,247 million of total assets. Its operating subsidiaries have been assigned a rating of “A+” (“Strong”) by Standard & Poor’s and “A+” (“Superior”) byA.M. Best . - Novae is headquartered in
London and is listed in theLondon Stock Exchange . It is a diversified property and casualty (re)insurance business operating through Syndicate 2007 at Lloyd’s. At4 July 2017 (being the last Business Day prior to the date of this Announcement), Novae had a market capitalisation of £374 million. As of31 December 2016 , Novae had shareholders’ equity of approximately £322 million and total assets of approximately £2,387 million. - Commenting on the Acquisition,
Albert Benchimol , President and CEO of AXIS, said:“We are very pleased to announce this proposed acquisition of Novae which will create a c.
$2 billion player in theLondon specialty market, anchored as a top 10 insurer in the Lloyd’s market. The acquisition is fully aligned with AXIS’s international specialty insurance growth strategy and will combine two highly complementary businesses, substantially enhancing our depth and breadth of product, underwriting expertise, and leadership capabilities to better serve our clients and brokers.We are excited about the opportunity to leverage the focused and profitable specialty insurance business Novae has created as part of a substantially larger group, with a larger capital base and a global platform. We expect the combined operations to benefit substantially from investments already made by AXIS to drive efficiencies across its international specialty insurance business and firmly believe this combination will create significant value for AXIS’s shareholders with limited execution risk. This transaction is expected to deliver meaningful earnings and ROE accretion within the first year after close.
We very much look forward to welcoming Novae’s employees to AXIS. Novae’s business is underpinned by the high calibre of its team, including its market leading underwriting talent, who we expect to thrive at AXIS, benefitting from access to a global platform and expanded resources. Our organizations share likeminded corporate cultures and we are deeply committed to ensuring a smooth integration process and creating a positive, collaborative environment that will breed success.”
- Commenting on the Acquisition,
John Hastings-Bass , Chairman of Novae, said:“The Board of Novae is pleased to unanimously recommend the AXIS offer, which represents an attractive outcome for Novae and provides certainty to Novae Shareholders at an attractive premium to the share price and net tangible assets per share. Over recent years, Novae has made significant progress on a standalone basis in developing its underwriting franchise and growing premiums in its targeted lines of business. However, it remains a relatively small player in a global industry. AXIS is a substantial and successful business which represents an excellent partner for the Novae business, its customers and employees.”
- Commenting on the Acquisition,
Matthew Fosh , Chief Executive Officer of Novae, said:“The combination of Novae and AXIS brings together two complementary businesses. We have long held AXIS in high regard, a company with whom we share a strong cultural compatibility. The transaction will provide the Novae business with the increased scale and financial resources needed to succeed in the current market. We look forward to working closely with the AXIS team on this next part of our journey.”
-
Credit Suisse International andFenchurch Advisory Partners LLP are acting as financial advisers to AXIS. Evercore is acting as financial adviser to Novae. - It is expected that the Scheme Document, containing further information about the Acquisition and notices of the Court Meeting and General Meeting, together with Forms of Proxy, will be posted to Novae Shareholders and (for information only) to participants of the Novae Share Schemes within 28 days of the date of this Announcement. Subject to the satisfaction or waiver of all relevant conditions, including the Conditions, and certain further terms set out in Appendix 1 to this Announcement and to be set out in the Scheme Document, it is expected that the Scheme will become Effective in Q4 2017. An expected timetable of principal events will be included in the Scheme Document.
- AXIS will host an investor teleconference, including a question and answer period, on
6 July 2017 at8:30 a.m. EDT to discuss this Announcement. The teleconference can be accessed by dialling +1 888-317-6003 (U.S. callers) or +1 412-317-6061 (international callers) and entering the passcode 7582829 approximately 10 minutes in advance of the call. A live, listen-only webcast of the call will also be available via the Investor Information section of AXIS’s website at www.axiscapital.com. - This summary should be read in conjunction with and is subject to the full text of this Announcement (including its Appendices). The Acquisition will be subject to the Conditions and the further terms set out in Appendix 1 and to the full terms and conditions to be set out in the Scheme Document. Appendix 2 contains the bases and sources of certain financial information contained in this Announcement. Appendix 3 contains details of the irrevocable undertakings received by AXIS. Appendix 4 contains the definitions of certain further terms used in this Announcement.
Enquiries
| |
||
|
|
+1 212 500 7600 | |
|
|
+1 212 500 7600 | |
|
|
+1 212 500 7600 | |
| |
||
|
|
+1 212 325 2000 | |
|
|
+1 212 325 2000 | |
|
|
+44 20 7888 8888 | |
|
Hugh Man |
+44 20 7888 8888 | |
| |
||
|
|
+44 20 7382 2222 | |
|
|
+44 20 7382 2222 | |
|
|
+44 20 7382 2222 | |
|
|
+44 20 7382 2222 | |
| |
||
|
|
+44 20 7050 9000 | |
|
Reeken Patel, Chief Financial Officer |
+44 20 7050 9000 | |
| |
||
|
|
+44 20 7653 6000 | |
|
|
+1 212 857 3100 | |
|
|
+44 20 7653 6000 | |
| |
||
|
|
+44 20 7523 8000 | |
|
|
+44 20 7523 8000 | |
Further Information
This Announcement is for information purposes only and is not intended to and does not constitute or form part of, any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Acquisition or otherwise nor shall there be any sale, issuance or transfer of securities of Novae in any jurisdiction in contravention of applicable law. The Acquisition will be implemented solely by means of the Scheme Document (or if the Acquisition is implemented by way of a Takeover Offer, the offer document), which will contain the full terms and conditions of the Acquisition including details of how to vote in respect of the Acquisition. Any vote in respect of the Scheme (or, if applicable, the Takeover Offer) or other response in relation to the Acquisition should be made only on the basis of the information contained in the Scheme Document (or, if applicable, acceptance under the offer document). Each Novae Shareholder is urged to consult his independent professional adviser immediately regarding the tax consequences of the Acquisition applicable to him.
Evercore, which is authorised and regulated by the
Overseas Jurisdictions
The release, publication or distribution of this Announcement in or into jurisdictions other than the
Copies of this Announcement and formal documentation relating to the Acquisition will not be, and must not be, mailed or otherwise forwarded, distributed or sent in, into or from any Restricted Jurisdiction or any jurisdiction where to do so would violate the laws of that jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in or into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of the Acquisition. If the Acquisition is implemented by way of Takeover Offer (unless otherwise permitted by applicable law or regulation), the Takeover Offer may not be made, directly or indirectly, in or into or from within any Restricted Jurisdiction.
The Acquisition relates to the shares of an English company that is a “foreign private issuer” as defined in Rule 3b4 under the
The receipt of cash pursuant to the Acquisition by a US beneficial owner of Novae Shares as consideration for the transfer of its Scheme Shares pursuant to the Scheme will be a taxable transaction for
If the Acquisition is implemented by way of a Takeover Offer and AXIS determines to extend such offer into
In accordance with normal
Further details in relation to Overseas Shareholders will be contained in the Scheme Document.
Forward-looking statements
This Announcement (including information incorporated by reference in this Announcement), oral statements made regarding the Acquisition, and other information published by AXIS and Novae contain statements which are, or may be deemed to be, “forward looking statements”. Such forward looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the
The forward looking statements speak only at the date of this Announcement. AXIS and Novae expressly disclaim any obligation to update such statements other than as required by law or by the rules of any competent regulatory authority, whether as a result of new information, future events or otherwise.
No profit forecasts
No statement in this Announcement is intended as a profit forecast or profit estimate and no statement in this Announcement should be interpreted to mean that earnings per Novae Share or AXIS Share for the current or future financial years would necessarily match or exceed the respective historical published earning per Novae Share or AXIS Share or to mean that the Enlarged Group’s earnings in the first 12 months following the Acquisition, or in any subsequent period, would necessarily match or be greater than those of AXIS or Novae for the relevant preceding financial period or any other period.
Disclosure requirements of the Takeover Code
Under Rule 8.3(a) of the Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person’s interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) of the Code applies must be made by no later than
Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person’s interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8 of the Code. A Dealing Disclosure by a person to whom Rule 8.3(b) of the Code applies must be made by no later than
If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.
Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4 of the Code).
Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel’s website at www.thetakeoverpanel.com, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel’s Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.
Electronic communications
Please be aware that addresses, electronic addresses and certain other information provided by Novae Shareholders, persons with information rights and other relevant persons for the receipt of communications from Novae may be provided to AXIS during the offer period as required under Section 4 of Appendix 4 of the Code to comply with Rule 2.11(c) of the Code.
The contents of the websites referred to in this Announcement are not incorporated into and do not form part of this Announcement.
Publication on website and hard copies
In accordance with Rule 26.1 of the Code, a copy of this Announcement will be published and made available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on AXIS’s website at www.axiscapital.com and Novae’s website at www.novae.com by no later than 12 noon on the Business Day following this Announcement. For the avoidance of doubt, the contents of those websites are not incorporated by reference into, and do not form part of, this Announcement.
Novae Shareholders and AXIS shareholders may request a hard copy of this Announcement by contacting the registrar of Novae during business hours on +44 (0) 370 707 1327 or by submitting a request in writing to
Rounding
Certain figures included in this Announcement have been subjected to rounding adjustments. Accordingly, figures shown for the same category presented in different tables may vary slightly and figures shown as totals in certain tables may not be an arithmetic aggregation of the figures that precede them.
Rule 2.9 requirement
In accordance with Rule 2.9 of the Code, Novae confirms that at the date of this Announcement, it has in issue and admitted to trading on the main market of the
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
FOR IMMEDIATE RELEASE
RECOMMENDED CASH OFFER
FOR
BY
1. INTRODUCTION
The boards of
2. SUMMARY OF THE ACQUISITION
Under the terms of the Acquisition, which will be subject to the Conditions and further terms set out in Appendix 1 of this Announcement (and the further terms and conditions to be set out in the Scheme Document), Scheme Shareholders will be entitled to receive:
for each Novae Share:
The consideration values the entire existing issued and to be issued share capital of Novae at approximately £467.6 million on the basis of a fully diluted share capital of 66,795,621 Novae Shares, calculated on the basis set out in paragraph 4 of Appendix 2.
The price of
- a premium of approximately 20 per cent. to the closing mid-market price of
581 pence per Novae Share on4 July 2017 , being the last Business Day before the date of this Announcement; and - a premium of approximately 29 per cent. to the volume weighted average closing price per Novae Share for the one month period up to and including
4 July 2017 , being the last Business Day before the date of this Announcement.
The consideration also implies a multiple of 1.5x Novae’s reported net tangible book value of £318.8 million as at
If, after the date of this Announcement, any dividend and/or other distribution and/or other return of capital is announced, declared or paid in respect of the Novae Shares, AXIS reserves the right to reduce the offer consideration by an amount up to the amount of such dividend and/or distribution and/or return of capital so announced, declared or paid, in which case any reference in this Announcement or the Scheme Document to the offer consideration for the Novae Shares will be deemed to be a reference to the offer consideration as so reduced. For further details, please refer to paragraph 15 of Part B of Appendix 1. For the avoidance of doubt, any payments made in cash or by way of the delivery of shares on the vesting of awards calculated by reference to dividends accrued in respect of those underlying vested shares are not to be construed as a dividend, distribution or return of capital for these purposes.
3. BACKGROUND TO AND REASONS FOR THE ACQUISITION
The Acquisition is a compelling opportunity to combine a leading specialty Lloyd’s franchise with a world-class international specialty (re)insurer, strengthening a broad, balanced and efficient global underwriting platform. The international specialty insurance businesses of AXIS and Novae are highly complementary and the combination of expertise from both businesses can be leveraged through AXIS’s scale and global platform. The Acquisition represents a new milestone in AXIS’s journey as a leading specialty (re)insurance franchise and strongly aligns with its insurance growth strategy. The Acquisition:
- provides further scale and relevance in international specialty insurance, with the combined business representing a top 10 player at Lloyd’s, with c.
$2 billion of gross premium written in theLondon specialty market; - represents the combination of two highly complementary international insurance businesses, providing AXIS with “lead” underwriting capability in a number of new classes of business, as well as broadened and deeper underwriting expertise in other specialty insurance classes; and
- significantly diversifies and enhances AXIS’s distribution platform, providing increased relevance with Lloyd’s brokers and access to market-leading programs / binding authority business (over 50 per cent. of Novae business is produced through specialist coverholder distribution which provides access to attractive SME and specialty personal lines business and makes it a leading underwriter of binder business at Lloyd’s).
The Acquisition is also expected to result in enhanced top line growth through access to AXIS’s broader global platform (including
The Acquisition is expected to be a financially compelling transaction for AXIS shareholders with access to expense synergies as well as top line growth. AXIS has identified up to
- operating EPS accretive in the first year with high single digit accretion expected by year 2;
- immediately accretive to operating return on equity;
- neutral to book value per share at close with accelerated growth post-close; and
- minimal impact to tangible book value per share at close with accelerated growth post-close.
4. RECOMMENDATION
Accordingly, the Novae Directors confirm that they intend unanimously to recommend that Novae Shareholders vote to approve the Scheme at the Court Meeting and vote in favour of the resolution to be proposed at the General Meeting as the Novae Directors who hold Novae Shares in their own name or through a nominee have irrevocably undertaken to do in respect of all of their own beneficial holdings of Novae Shares.
5. BACKGROUND TO AND REASONS FOR THE RECOMMENDATION
Novae is a diversified property and casualty (re)insurance business that has been operating in the Lloyd’s market for over 30 years. It has made strong progress in terms of the scale of its franchise (with total gross written premium of £901 million for 2016), driving value for shareholders by focussing on underwriting excellence.
However, Novae remains a relatively small player within the global insurance industry, which itself has seen considerable consolidation over recent years. Furthermore, in response to challenging market conditions, the business has been proactively reducing its exposure to less profitable classes of business (as highlighted by Novae’s trading update announced on
The increased prevalence of large and catastrophic losses during 2016, together with the one-off impact of the Ogden provision and other accounting charges taken in the year, have resulted in a decline in Novae’s net assets and capital. As a consequence, Novae’s scope to take full advantage of the profitable growth opportunities within its core classes on a stand-alone basis will be constrained, with the resulting profit recovery likely more muted than if Novae had greater capital resources at its disposal.
- the strategic benefits from scale that Novae will benefit from by combining with AXIS, in an industry that has undergone considerable consolidation in recent years;
- the enhanced opportunities that Novae will have as part of a larger group, particularly in terms of the distribution of its specialty products, through access to the broader AXIS platform;
- increased relevance to brokers and intermediaries on a combined basis; and
- the cultural compatibility of the two organisations with significant and improved opportunities for Novae staff as part of the
Enlarged Group .
6. MANAGEMENT, EMPLOYEES AND BUSINESS OF NOVAE
AXIS attaches great importance to the skills and experience of the existing management and employees of the
AXIS confirms that, following completion of the Acquisition, the existing contractual and statutory employment rights of, and pension obligations owed to, existing management and employees of the
It is anticipated that Novae will be merged into the international division of AXIS’s insurance segment and, as part of the process, that Novae will adopt the AXIS Insurance International brand. It is envisaged that the integration process will take approximately one year to complete and will eventually lead to the relocation of Novae personnel to shared office space in
It is expected that, following completion of the Acquisition,
7. DIRECTORS’ IRREVOCABLE UNDERTAKINGS
AXIS has received irrevocable undertakings to vote in favour of the Scheme at the Court Meeting and the resolution to be proposed at the General Meeting from those of the Novae Directors who hold Novae Shares in their own name or through a nominee in respect of all their own beneficial holdings of Novae Shares. The undertakings from the Novae Directors will cease to be binding only if (among other things) the Scheme lapses or is withdrawn and remain binding in the event that a higher competing offer for Novae is made.
Copies of the irrevocable undertakings will be on display on AXIS’s website at www.axiscapital.com and Novae’s website at www.novae.com from 12 noon on
Further details of these irrevocable undertakings are set out in Appendix 3 of this Announcement.
8. INFORMATION RELATING TO AXIS
Established in 2001, AXIS is a
AXIS listed on the
AXIS is segmented into two global underwriting platforms:
-
AXIS Insurance , provides a customised coverage for property, liability, marine, energy, aviation, terrorism, professional lines, political risk, accident and health, credit risk and other specialty risks on a worldwide basis; and - AXIS Reinsurance, provides non-life reinsurance to insurance companies on a worldwide basis.
For the year ending
9. FINANCING
The consideration will be funded from AXIS’s existing cash resources or, if market conditions are favourable, from new borrowings.
Each of
10. INFORMATION RELATING TO NOVAE
Novae is a diversified property and casualty (re)insurer headquartered in
Novae is segmented into two main divisions:
- Property, including US,
UK and European Property Facilities, Medical Malpractice and Property Reinsurance; and - Marine, Aviation, Political Risk and Specialty, including Cyber, Marine & Energy, Political & Credit, US Excess Casualty and Aviation Reinsurance.
For the year ending
The Novae Group’s business has a proactive strategy focused on expert underwriting, consistent performance and dynamic capital management. As part of this, Novae has re-focused on a select number of core lines of business where it has underwriting expertise and can produce sustainable profits (core lines comprise Novae’s “Invest” and “Maintain” classes which delivered an average combined ratio of 80 per cent. between 2013 and 2016). Since 2013, this has resulted in Novae exiting 15 classes of business in lines where it does not hold leading offerings or where rates are under persistent market pressure, and growing its attractive core classes by approximately £410 million.
11. NOVAE SHARE SCHEMES
Participants in any of the Novae Share Schemes will be contacted regarding the effect of the Acquisition on their rights under those plans and provided with further details concerning the proposals which will be made to them in due course.
Appropriate proposals will be made to the holders of vested and unvested awards under the Novae Share Schemes.
12. OFFER-RELATED ARRANGEMENTS
AXIS and Novae have entered into a confidentiality agreement dated 6
Novae and AXIS have also entered into the Share Scheme Letter containing certain provisions that will apply in respect of the Novae Share Schemes, directors’ and officers’ insurance and certain other arrangements relating to employees.
13. STRUCTURE OF THE ACQUISITION
It is intended that the Acquisition will be implemented by means of a Court sanctioned scheme of arrangement under Part 26 of the Companies Act. The Scheme is an arrangement between Novae and the Scheme Shareholders and is subject to the approval of the Court. The procedure involves, among other things, an application by Novae to the Court to sanction the Scheme, in consideration for which Scheme Shareholders will receive cash on the basis described in paragraph 2 above. The purpose of the Scheme is to provide for AXIS to become the owner of the entire issued and to be issued share capital of Novae.
The Acquisition is subject to a number of Conditions and certain further terms set out in Appendix 1 to this Announcement and to the full terms and conditions to be set out in the Scheme Document, and will only become Effective if, among other things, the following events occur on or before the Longstop Date:
- a resolution to approve the Scheme is passed by a majority in number of the Scheme Shareholders present and voting (and entitled to vote) at the Court Meeting, either in person or by proxy, representing 75 per cent. or more in value of the Scheme Shares held by those Scheme Shareholders;
- the Special Resolution necessary to implement the Scheme is passed at the General Meeting (which will require the approval of Novae Shareholders representing at least 75 per cent. of the votes cast at the General Meeting), which is expected to be held immediately after the Court Meeting;
- following the Novae Meetings, the Scheme is sanctioned by the Court (without modification or with modification on terms agreed by AXIS and Novae); and
- following such sanction, an office copy of the Scheme Court Order is delivered to the Registrar of Companies of
England andWales .
Upon the Scheme becoming Effective: (i) it will be binding on all Novae Shareholders, irrespective of whether or not they attended or voted at the Court Meeting and the General Meeting (and if they attended and voted, whether or not they voted in favour); and (ii) share certificates in respect of Novae Shares will cease to be of value and should be destroyed and entitlements to Novae Shares held within the CREST system will be cancelled. The consideration payable under the Scheme will be despatched to Scheme Shareholders by AXIS no later than 14 days after the Effective Date.
Any Novae Shares issued before the Scheme Record Time will be subject to the terms of the Scheme. The Special Resolution to be proposed at the General Meeting will, amongst other matters, provide that the Articles be amended to incorporate provisions requiring any Novae shares issued after the Scheme Record Time (other than to AXIS and/or its nominees) to be automatically transferred to AXIS on the same terms as the Acquisition (other than terms as to timings and formalities). The provisions of the Articles (as amended) will avoid any person (other than AXIS and its nominees) holding shares in the capital of Novae after the Effective Date.
The Scheme will lapse and the Acquisition will not proceed if:
- the Court Meeting and the General Meeting are not held by the 22nd day after the expected date of such meetings to be set out in the Scheme Document in due course; or
- the Scheme does not become Effective by the Longstop Date,
provided however that the deadlines for the timing of the Court Meeting and the General Meeting and the deadline for the Scheme to become Effective may be extended by agreement between AXIS and Novae, with the approval of the Court and/or the consent of the Panel, if required.
The Scheme will lapse and will not become Effective if:
(a) insofar as the Merger constitutes, or is deemed to constitute, a concentration with an EU dimension within the scope of the Regulation, the
(b) in so far as the Merger does not constitute, or is not deemed to constitute, a concentration with an EU dimension within the scope of the Regulation, the Merger or any matter arising from or relating to it becomes subject to a reference to the chair of the CMA for the constitution of a group under schedule 4 to the Enterprise and Regulatory Reform Act 2013,
in either case, before the date of the Court Meeting and the General Meeting.
The Acquisition is conditional, amongst others, on the PRA and the
It is expected that the Scheme Document, containing further information about the Acquisition and notices of the Court Meeting and General Meeting, together with Forms of Proxy, will be posted to Novae Shareholders and (for information only) to participants of the Novae Share Schemes within 28 days of the date of this Announcement. Subject to the satisfaction or waiver of all relevant conditions, including the Conditions, and certain further terms set out in Appendix 1 to this Announcement and to be set out in the Scheme Document, it is expected that the Scheme will become Effective in Q4 2017. An expected timetable of principal events will be included in the Scheme Document.
14. DISCLOSURE OF INTERESTS IN NOVAE
As at the close of business on
In the interests of secrecy prior to releasing this Announcement, it has not been practicable for AXIS to have made any enquiries of certain parties who may be deemed by the Panel to be acting in concert with AXIS. Enquiries of such parties will be made as soon as practicable following the date of this Announcement and AXIS confirms that further disclosure in accordance with Rule 8.1(a) and Note 2(a)(i) on Rule 8 of the Code will be made as soon as possible, if required.
15. DELISTING AND RE-REGISTRATION
It is intended that dealings in Novae Shares should be suspended shortly prior to the Effective Date at a time to be set out in the Scheme Document. It is further intended that an application will be made to the
Share certificates in respect of the Novae Shares will cease to be valid and should be destroyed on the first Business Day following the Effective Date.
In addition, entitlements held within the CREST system to the Novae Shares will be cancelled on the first Business Day following the Effective Date.
16. OVERSEAS SHAREHOLDERS
The release, publication or distribution of this Announcement in or into jurisdictions other than the
This Announcement is for information purposes only and is not intended to and does not constitute or form part of, any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Acquisition or otherwise nor shall there be any sale, issuance or transfer of securities of Novae in any jurisdiction in contravention of applicable law. The Acquisition will be implemented solely by means of the Scheme Document (or if the Acquisition is implemented by way of a Takeover Offer, the offer document), which will contain the full terms and conditions of the Acquisition including details of how to vote in respect of the Acquisition. Any vote in respect of the Scheme (or, if applicable, the Takeover Offer) or other response in relation to the Acquisition should be made only on the basis of the information contained in the Scheme Document (or, if applicable, acceptance under the offer document). Each Novae Shareholder is urged to consult his independent professional adviser immediately regarding the tax consequences of the Acquisition applicable to him.
17. DOCUMENTS PUBLISHED ON A WEBSITE
Copies of the following documents will, no later than 12 noon on
- this Announcement;
- the irrevocable undertakings referred to in paragraph 7 (further details of which are set out in Appendix 3 of this Announcement); and
- the confidentiality agreement and the Share Scheme Letter referred to in paragraph 12.
The contents of Novae’s website and AXIS’s website are not incorporated into and do not form part of this Announcement.
18. GENERAL
The Acquisition will be subject to the Conditions and certain further terms set out in Appendix 1 and the further terms and conditions to be set out in the Scheme Document when issued.
AXIS shall be entitled to implement the Acquisition by way of a Takeover Offer rather than the Scheme with the consent of the Panel.
If the Acquisition is effected by way of a Takeover Offer and such Takeover Offer becomes or is declared unconditional in all respects and sufficient acceptances are received, AXIS intends to exercise its rights to apply the provisions of Chapter 3 of Part 28 of the Companies Act to acquire compulsorily the remaining Novae Shares in respect of which the Takeover Offer has not been accepted.
The Acquisition will be governed by English law and will be subject to the jurisdiction of the courts of
The sources of certain financial information and bases of calculation contained in this Announcement are set out in Appendix 2. Certain terms used in this Announcement are defined in Appendix 4.
Enquiries
| |
+1 212 500 7600 +1 212 500 7600 +1 212 500 7600 |
|
| Hugh Man |
+1 212 325 2000 +1 212 325 2000 +44 20 7888 8888 +44 20 7888 8888 |
|
| |
+44 20 7382 2222 +44 20 7382 2222 +44 20 7382 2222 +44 20 7382 2222 |
|
| Reeken Patel, Chief Financial Officer |
+44 20 7050 9000 +44 20 7050 9000 |
|
|
|
+44 20 7653 6000 +1 212 857 3100 +44 20 7653 6000
+44 20 7523 8000 +44 20 7523 8000 |
|
Further Information
This Announcement is for information purposes only and is not intended to and does not constitute or form part of, any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Acquisition or otherwise nor shall there be any sale, issuance or transfer of securities of Novae in any jurisdiction in contravention of applicable law. The Acquisition will be implemented solely by means of the Scheme Document (or if the Acquisition is implemented by way of a Takeover Offer, the offer document), which will contain the full terms and conditions of the Acquisition including details of how to vote in respect of the Acquisition. Any vote in respect of the Scheme (or, if applicable, the Takeover Offer) or other response in relation to the Acquisition should be made only on the basis of the information contained in the Scheme Document (or, if applicable, acceptance under the offer document). Each Novae Shareholder is urged to consult his independent professional adviser immediately regarding the tax consequences of the Acquisition applicable to him.
Evercore, which is authorised and regulated by the
Overseas Jurisdictions
The release, publication or distribution of this Announcement in or into jurisdictions other than the
Copies of this Announcement and formal documentation relating to the Acquisition will not be, and must not be, mailed or otherwise forwarded, distributed or sent in, into or from any Restricted Jurisdiction or any jurisdiction where to do so would violate the laws of that jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send them in or into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of the Acquisition. If the Acquisition is implemented by way of Takeover Offer (unless otherwise permitted by applicable law or regulation), the Takeover Offer may not be made, directly or indirectly, in or into or from within any Restricted Jurisdiction.
The Acquisition relates to the shares of an English company that is a “foreign private issuer” as defined in Rule 3b4 under the
The receipt of cash pursuant to the Acquisition by a US beneficial owner of Novae Shares as consideration for the transfer of its Scheme Shares pursuant to the Scheme will be a taxable transaction for
If the Acquisition is implemented by way of a Takeover Offer and AXIS determines to extend such offer into
In accordance with normal
Further details in relation to Overseas Shareholders will be contained in the Scheme Document.
Forward-looking statements
This Announcement (including information incorporated by reference in this Announcement), oral statements made regarding the Acquisition, and other information published by AXIS and Novae contain statements which are, or may be deemed to be, “forward looking statements”. Such forward looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the
The forward looking statements speak only at the date of this Announcement. AXIS and Novae expressly disclaim any obligation to update such statements other than as required by law or by the rules of any competent regulatory authority, whether as a result of new information, future events or otherwise.
No profit forecasts
No statement in this Announcement is intended as a profit forecast or profit estimate and no statement in this Announcement should be interpreted to mean that earnings per Novae Share or AXIS Share for the current or future financial years would necessarily match or exceed the respective historical published earning per Novae Share or AXIS Share or to mean that the Enlarged Group’s earnings in the first 12 months following the Acquisition, or in any subsequent period, would necessarily match or be greater than those of AXIS or Novae for the relevant preceding financial period or any other period.
Disclosure requirements of the Takeover Code
Under Rule 8.3(a) of the Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person’s interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) of the Code applies must be made by no later than
Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person’s interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8 of the Code. A Dealing Disclosure by a person to whom Rule 8.3(b) of the Code applies must be made by no later than
If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.
Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4 of the Code).
Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel’s website at www.thetakeoverpanel.com, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel’s Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.
Electronic communications
Please be aware that addresses, electronic addresses and certain other information provided by Novae Shareholders, persons with information rights and other relevant persons for the receipt of communications from Novae may be provided to AXIS during the offer period as required under Section 4 of Appendix 4 of the Code to comply with Rule 2.12(c).
The contents of the websites referred to in this Announcement are not incorporated into and do not form part of this Announcement.
Publication on website and hard copies
In accordance with Rule 26.1 of the Code, a copy of this Announcement will be published and made available, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on AXIS’s website at www.axiscapital.com and Novae’s website at www.novae.com by no later than 12 noon on the Business Day following this Announcement. For the avoidance of doubt, the contents of those websites are not incorporated by reference into, and do not form part of, this Announcement.
Novae Shareholders and AXIS shareholders may request a hard copy of this Announcement by contacting the registrar of Novae during business hours on +44 (0) 370 707 1327 or by submitting a request in writing to
Rounding
Certain figures included in this Announcement have been subjected to rounding adjustments. Accordingly, figures shown for the same category presented in different tables may vary slightly and figures shown as totals in certain tables may not be an arithmetic aggregation of the figures that precede them.
Rule 2.9 requirement
In accordance with Rule 2.9 of the Code, Novae confirms that at the date of this Announcement, it has in issue and admitted to trading on the main market of the
APPENDIX 1
CONDITIONS AND CERTAIN FURTHER TERMS TO THE ACQUISITION AND THE SCHEME
PART A: CONDITIONS TO THE SCHEME AND THE ACQUISITION
SCHEME CONDITIONS
1. The Acquisition will be conditional upon the Scheme becoming unconditional and becoming Effective, subject to the provisions of the Code, by no later than the Longstop Date.
2. The Scheme will be subject to the following conditions:
2.1. its approval by a majority in number of Scheme Shareholders who are on the register of members of Novae at the Voting Record Time, present and voting, whether in person or by proxy, representing 75 per cent. or more in value of the Scheme Shares held by those Scheme Shareholders, at the Court Meeting (or any adjournment thereof, provided that the Court Meeting may not be adjourned beyond the 22nd day after the expected date of the Court Meeting to be set out in the Scheme Document in due course, or such later date (if any) as AXIS and Novae may agree and the Court may allow);
2.2. all resolutions required to approve and implement the Scheme (including, without limitation, the Special Resolution) being duly passed by the requisite majority at the General Meeting (or any adjournment thereof, provided that the General Meeting may not be adjourned beyond the 22nd day after the expected date of the General Meeting to be set out in the Scheme Document in due course, or such later date (if any) as AXIS and Novae may agree and the Court may allow); and
2.3. the sanction (without modification or with modification on terms acceptable to AXIS and Novae) of the Scheme by the Court, provided that the Scheme Court Hearing may not be adjourned beyond the 22nd day after the expected date of the Scheme Court Hearing to be set out in the Scheme Document in due course, or such later date (if any) as AXIS and Novae may agree and the Court may allow, and an office copy of the Scheme Court Order being delivered to the Registrar of Companies of
GENERAL CONDITIONS
3. AXIS and Novae have agreed that, subject as stated below and to the requirements of the Panel, the Acquisition will also be conditional upon, and accordingly the necessary actions to make the Acquisition Effective will only be taken on, the satisfaction or waiver of the following Conditions:
Regulatory and merger control clearances
3.1. the PRA:
(a) having given notice of its unconditional approval in writing under section 189(4)(a) of FSMA, or having given notice of its conditional approval by means of a decision notice under section 189(7) of FSMA on terms satisfactory to AXIS acting reasonably; or
(b) being treated as having given its approval by virtue of section 189(6) of FSMA,
in respect of any increase in or acquisition of control (as defined in sections 181 and 182 of FSMA) over
3.2. the
(a) having given notice of its unconditional approval in writing under section 189(4)(a) of FSMA, or having given notice of its conditional approval by means of a decision notice under section 189(7) of FSMA on terms satisfactory to AXIS acting reasonably; or
(b) being treated as having given its approval by virtue of section 189(6) of FSMA,
in respect of any increase in control (as defined in sections 181 and 182 of FSMA) over
Lloyd’s of
3.3. Lloyd's (acting through the Council of Lloyd’s or its Franchise Board, as the case may be) having given its consent in writing, pursuant to (i) paragraph 12 of the Lloyd's Membership Byelaw, in respect of each member of the
3.4. the BMA having given written notice that it has no objection to any change in the shareholder controller(s) of
Merger control
3.5. the
3.6. to the extent that the
3.7. all notifications to, and filings with, Third Parties which are necessary in order to allow the Acquisition to close having been made, all necessary waiting and other time periods (including any extensions of such waiting and other time periods) under any applicable legislation or regulation of any relevant jurisdiction having expired, lapsed or been terminated (as appropriate) and all statutory or regulatory obligations in any relevant jurisdiction having been complied with in each case in connection with the Scheme or Acquisition or the acquisition of any shares or other securities in, or control of, Novae or any other member of the wider
3.8. no Third Party whose consent or nonintervention is required in order to allow the Acquisition to close having intervened (as defined in paragraph 4.4 below) which would or might reasonably be expected to (in each case, which is material in the context of the wider
(a) make the Scheme or the Acquisition or, in each case, its implementation or the acquisition or proposed acquisition by AXIS or any member of the wider
(b) materially limit or delay, or impose any material limitations on, the ability of any member of the wider
(c) require, prevent or materially delay the divestiture by any member of the wider
(d) require, prevent or materially delay the divestiture by any member of the wider
(e) except pursuant to sections 974 to 991 of the Companies Act, require any member of the wider
(f) materially limit the ability of any member of the wider
(g) result in any member of the wider
(h) otherwise materially adversely affect any or all of the business, assets, value, profits, operational performance, financial or trading position or prospects of any member of the wider
and all applicable waiting and other time periods (including extensions thereof) during which any Third Party whose consent is required in order to allow the Acquisition to close could intervene (as defined in 4.4 below) under the laws of any relevant jurisdiction having expired, lapsed or been terminated;
3.9. all material Authorisations which are necessary in order to allow the Acquisition to close in any relevant jurisdiction for or in respect of the Scheme or Acquisition or the acquisition or proposed acquisition of any shares or other securities in, or control of, Novae or any other member of the wider
Certain matters arising as a result of any arrangement, agreement etc.
3.10. except as Disclosed, there being no provision of any agreement, arrangement, licence, permit, franchise, lease or other instrument to which any member of the wider
(a) any monies borrowed by or any other indebtedness (actual or contingent) of, or grant available to any such member, being or becoming repayable or capable of being declared repayable immediately or earlier than their or its stated maturity date or repayment date or the ability of any such member to borrow monies or incur any indebtedness being withdrawn or inhibited or being capable of becoming or being withdrawn or inhibited;
(b) any such agreement, arrangement, licence, permit, franchise, lease or instrument or the rights, liabilities, obligations, interests or business of any such member thereunder being, or becoming capable of being, terminated or adversely modified or adversely affected or any obligation or liability arising thereunder or any adverse action being taken thereunder;
(c) any assets or interests of any such member being or falling to be disposed of or charged or ceasing to be available to any such member or any right arising under which any such asset or interest could be required to be disposed of or charged or could cease to be available to any such member otherwise than in the ordinary course of business;
(d) the creation or enforcement of any mortgage, charge or other security interest over the whole or any part of the business, property or assets of any such member or any such mortgage, charge or other security interest (wherever created, arising or having arisen) being enforced or becoming enforceable otherwise than in the ordinary course of business;
(e) the rights, liabilities, obligations or interests of any such member under any such agreement, arrangement, licence, permit, franchise, lease or other instrument, or the interests or business of any such member in or with, any person, firm, company or body (or any arrangement or arrangements relating to any such interests or business) being terminated, adversely modified or adversely affected or any onerous obligation or liability arising or any adverse action being taken or arising thereunder;
(f) the business, assets, value, profits or operational performance of any such member or its financial or trading position being prejudiced or adversely affected;
(g) any such member ceasing to be able to carry on business under any name under which it presently does so;
(h) the creation or acceleration of any liability, actual or contingent, by any such member or for which any such member may be responsible other than liabilities incurred in the ordinary course of business;
(i) the creation or acceleration of any liability to taxation of any such member other than liabilities incurred in the ordinary course of business; or
(j) any liability of any such member to make any severance, termination, bonus or other payment to any of its directors or other officers other than where such liabilities are incurred in the ordinary course of business,
and no event having occurred which, under any provision of any agreement, arrangement, licence, permit, franchise, lease or other instrument to which any member of the wider
3.11. except as Disclosed, no member of the wider
(a) save as between Novae and whollyowned subsidiaries of Novae or for Novae Shares issued pursuant to the exercise of options, awards and other rights granted under the Novae Share Schemes, issued, agreed to issue, authorised the issue or proposed the issue of additional shares of any class;
(b) sold or transferred or agreed to sell or transfer any Novae Shares held by Novae as treasury shares except for the issue or transfer out of treasury of Novae Shares on the exercise of employee share options or vesting of employee share awards;
(c) save as between Novae and whollyowned subsidiaries of Novae or for the grant of options, awards and other rights under the Novae Share Schemes, issued or agreed to issue, authorised or proposed the issue of securities convertible or exchangeable into shares of any class or rights, warrants or options to subscribe for, or acquire, any such shares or convertible or exchangeable securities;
(d) except in relation to necessary changes made or agreed as a result of or arising from, changes to legislation, made or agreed or consented to any significant change to: (i) the terms of the trust deeds, rules, policy or other governing documents constituting any pension scheme or other retirement or death benefit arrangement established for the directors, former directors, employees or former employees of any entity in the wider
(e) carried out any act: (i) which would or could reasonably be expected to lead to the commencement of the winding up of any Relevant Pension Plan; (ii) which would or might create a material debt owed by an employer to any Relevant Pension Plan; or (iii) which would or might accelerate any material obligation on any employer to fund or pay additional contributions to any Relevant Pension Plan;
(f) other than to another member of the
(g) other than pursuant to the Acquisition and save as between Novae and its whollyowned subsidiaries or between wholly-owned subsidiaries of Novae and save for any transaction in the ordinary course of business, merged or demerged with any body corporate, partnership or business or acquired or disposed of or transferred, mortgaged or charged or created any security interest over any assets or any right, title or interest in any asset (including shares and trade investments) or authorised or proposed or announced any intention to propose any merger, demerger, acquisition or disposal, transfer, mortgage, charge or security interest, in each case to an extent which is material in the context of the wider
(h) save as between Novae and its whollyowned subsidiaries or between wholly-owned subsidiaries of Novae, made or authorised or proposed or announced an intention to propose any change in its loan capital, in each case, (i) other than in the ordinary course of business and (ii) to an extent which is material in the context of the wider
(i) issued or authorised or proposed the issue of, or made any change in or to, any debentures or (except as between Novae and its whollyowned subsidiaries or between wholly-owned subsidiaries of Novae) incurred or increased any indebtedness or become subject to any guarantee or liability (actual or contingent), in each case (i) other than in the ordinary course of business and (ii) to an extent which is material in the context of the wider
(j) purchased, redeemed or repaid or announced any proposal to purchase, redeem or repay any of its own shares or other securities or reduced or made any other change to any part of its share capital, in each case, to an extent which is material in the context of the wider
(k) other than pursuant to the Acquisition (and except for transactions between Novae and its whollyowned subsidiaries or between wholly-owned subsidiaries of Novae or transactions in the ordinary course of business) implemented, or authorised, proposed or announced its intention to implement, any reconstruction, amalgamation, scheme, commitment or other transaction or arrangement, in each case, to an extent which is material in the context of the wider
(l) entered into or varied the terms of any contract, agreement or arrangement with any director or senior executive of any member of the wider
(m) entered into or varied or authorised, proposed or announced its intention, other than in the ordinary course of business, to enter into or vary any contract, transaction, arrangement or commitment (whether in respect of capital expenditure or otherwise) which is of a long term, onerous or unusual nature or magnitude or which involves an obligation of such a nature or magnitude, and in each such case is or would be reasonably likely to be material in the context of the wider
(n) other than in respect of a member which was dormant and solvent at the relevant time, taken any corporate action or had any legal proceedings started or threatened in writing against it or petition presented or order made for its windingup (voluntarily or otherwise), striking off, dissolution or reorganisation or for the appointment of a receiver, administrative receiver, administrator (including the filing of an administration application, notice of intention to appoint an administrator or notice of appointment of an administrator), trustee or similar officer of all or any material part of its assets or revenues or any analogous proceedings in any jurisdiction or had any such person appointed which in any case is material in the context of the
(o) been unable, or admitted in writing that it is unable, to pay its debts or having stopped or suspended (or threatened to stop or suspend) payment of its debts generally or proposed or entered into any composition or voluntary arrangement with its creditors (or any class of them) or the filing at court of documentation in order to obtain a moratorium prior to a voluntary arrangement or, by reason of actual or anticipated financial difficulties, commenced negotiations with one or more of its creditors with a view to rescheduling any of its indebtedness, in each case, to an extent which is material in the context of the wider
(p) entered into any contract, transaction or arrangement which would be restrictive on the business of any member of the wider
(q) otherwise than in respect of claims between Novae and its wholly-owned subsidiaries, waived or compromised any claim which is or would be reasonably likely to be material in the context of the wider
(r) made any alteration to its memorandum or articles of association which is material in the context of the Scheme or the Acquisition or the acquisition by any member of the wider
(s) proposed, agreed to provide or modified the terms of any share option scheme, incentive scheme or other benefit relating to the employment or termination of employment of any person employed by the wider
(t) other than in the ordinary course of business, entered into any contract, commitment, arrangement or agreement or passed any resolution or made any offer (which remains open for acceptance) with respect to or announced any intention to, or to propose to, effect any of the transactions, matters or events referred to in this Condition 3.11;
No adverse change, litigation or regulatory enquiry
3.12. since
(a) no material adverse change or deterioration having occurred in the business, assets, value, financial or trading position, profits, operational performance or prospects of the wider
(b) other than as a result of the Acquisition, no litigation, arbitration proceedings, prosecution or other legal proceedings to which any member of the wider
(c) (other than as a result of or in connection with the Acquisition) no enquiry or investigation by, or complaint or reference to, any Third Party having been threatened, announced, implemented, instituted by or against or remaining outstanding against or in respect of any member of the wider
(d) no contingent or other liability having arisen which would have or would reasonably be expected to have a material adverse effect on the wider
(e) no steps having been taken and no omissions having been made which are likely to result in the withdrawal, cancellation, termination or modification of any licence held by any member of the wider
(f) other than with the consent of AXIS, no action having been taken or proposed by any member of the wider
(g) no member of the wider
No discovery of certain matters
3.13. save as Disclosed, AXIS not having discovered:
(a) that any financial, business or other information concerning the wider
(b) that any member of the wider
(c) any information which affects the import of any information Disclosed at any time prior to this Announcement by or on behalf of any member of the wider
Anti-corruption, sanctions and criminal property
3.14. save as Disclosed, AXIS not having discovered:
(a) that any past or present member, director, officer or employee of the wider
(b) any material asset of any member of the wider
(c) that any past or present member, director, officer or employee of the of wider
(d) a member of the
4. For the purposes of these Conditions:
4.1. “Authorisations” means authorisations, orders, grants, recognitions, determinations, certificates, confirmations, consents, licences, clearances, notifications, filings, permissions and approvals, in each case, of a Third Party;
4.2. “Disclosed” means information which has been fairly disclosed by or on behalf of Novae: (i) in the annual report and accounts of the
4.3. “Third Party” means any central bank, government, government department or governmental, quasigovernmental, supranational, statutory, regulatory, environmental or investigative body, authority (including any national or supranational anti-trust or merger control authority), court, trade agency, association, institution or professional or environmental body or any other body or person whatsoever in any jurisdiction (including, for the avoidance of doubt, the Panel);
4.4. a Third Party shall be regarded as having “intervened” if it has decided to take, institute, implement or threaten any action, proceeding, suit, investigation, enquiry or reference or made, proposed or enacted any statute, regulation, decision or order or taken any measures or other steps or required any action to be taken or information to be provided and "intervene" shall be construed accordingly; and
4.5. the “wider
PART B: FURTHER TERMS AND CONDITIONS
Waiver and invocation of the Conditions
5. The Scheme will not become Effective unless the Conditions have been fulfilled or (if capable of waiver) waived or, where appropriate, have been determined by AXIS to be or remain satisfied by no later than the Longstop Date.
6. Subject to the requirements of the Panel, AXIS reserves the right to waive, in whole or in part, all or any of the above Conditions, except Condition 2.
7. Conditions 3.1 to 3.14 (inclusive) must be fulfilled, or waived, by no later than
8. AXIS undertakes that it will, immediately before the Scheme Court Hearing, provide notice in writing to Novae that either (i) the Conditions (except Condition 2) have each been satisfied or that AXIS has waived or treated as satisfied such Conditions or (ii) to the extent permitted by the Panel, it intends to invoke or treat as incapable of satisfaction each or any Condition.
9. Each of the Conditions shall be regarded as a separate Condition and shall not be limited by reference to any other Condition.
Implementation by way of Takeover Offer
10. Subject to obtaining the consent of the Panel, AXIS reserves the right to elect to implement the Acquisition by way of a Takeover Offer as an alternative to the Scheme. In such event, such Takeover Offer will be implemented on substantially the same terms and conditions, so far as applicable, as those which would apply to the Scheme subject to appropriate amendments to reflect the change in method of effecting the Takeover Offer, including (without limitation) the inclusion of an acceptance condition set at 75 per cent. (or such lower percentage as AXIS may, subject to the rules of the Code and with the consent of the Panel, decide) of the Novae Shares to which the Takeover Offer relates or, where any of the circumstances set out in Note 2 of Section 8 of Appendix 7 of the Code applies, 90 per cent. of the Novae Shares to which the Takeover Offer relates (or such other percentage, being more than 50 per cent. of the Novae Shares to which the Takeover Offer relates, as AXIS may, subject to the rules of the Code and with the consent of the Panel, decide).
Certain further terms of the Acquisition
11. Under Rule 13.5(a) of the Code, AXIS may not invoke a Condition to the Acquisition so as to cause the Acquisition not to proceed, to lapse or to be withdrawn unless the circumstances which give rise to the right to invoke the Condition are of material significance to AXIS in the context of the Acquisition. Condition 2 and, if applicable, any acceptance condition if the Acquisition is implemented by means of a Takeover Offer, are not subject to this provision of the Code.
12. If AXIS is required by the Panel to make an offer for Novae Shares under the provisions of Rule 9 of the Code, AXIS may make such alterations to any of the above Conditions as are necessary to comply with the provisions of that Rule.
13. The Scheme will lapse and will not become Effective if:
(a) insofar as the Merger constitutes, or is deemed to constitute, a concentration with an EU dimension within the scope of the Regulation, the
(b) in so far as the Merger does not constitute, or is not deemed to constitute, a concentration with an EU dimension within the scope of the Regulation, the Merger or any matter arising from or relating to it becomes subject to a reference to the chair of the CMA for the constitution of a group under schedule 4 to the Enterprise and Regulatory Reform Act 2013,
in either case, before the date of the Court Meeting and the General Meeting.
14. Novae Shares will be acquired by AXIS fully paid and free from all liens, equitable interests, charges, encumbrances, rights of preemption and other third party rights of any nature whatsoever and together with all rights attaching to them as at the date of this Announcement or subsequently attaching or accruing to them, including the right to receive and retain, in full, all dividends and other distributions (if any) paid or payable, or any other return of capital made, on or after the date of this Announcement.
15. If, on or after the date of this Announcement, any dividend and/or other distribution and/or other return of capital is announced, declared or paid in respect of the Novae Shares, AXIS reserves the right (without prejudice to any right of AXIS to invoke Condition 3.11(f)), to reduce the offer consideration for the Novae Shares by an amount up to the amount of such dividend and/or distribution and/or return of capital so announced, declared or paid, in which case any reference in this Announcement or in the Scheme Document to the offer consideration for the Novae Shares will be deemed to be a reference to the offer consideration as so reduced. To the extent that any such dividend and/or distribution and/or other return of capital is announced, declared or paid and it is: (i) transferred pursuant to the Acquisition on a basis which entitles AXIS to receive the dividend or distribution and to retain it; or (ii) cancelled, the offer consideration will not be subject to change in accordance with this paragraph. Any exercise by AXIS of its rights referred to in this paragraph shall be the subject of an announcement and, for the avoidance of doubt, shall not be regarded as constituting any revision or variation of the Acquisition. For the further avoidance of doubt, any payments made in cash or by way of the delivery of shares on the vesting of awards calculated by reference to dividends accrued in respect of those underlying vested shares are not to be construed as a dividend, distribution or return of capital for these purposes.
16. The Acquisition will be subject, inter alia, to the Conditions and certain further terms which are set out in this Appendix 1 and those terms which will be set out in the Scheme Document and the Share Scheme Letter and such further terms as may be required to comply with the Listing Rules and the provisions of the Code.
17. The availability of the Acquisition to persons not resident in the
18. This Announcement and any rights or liabilities arising hereunder, the Acquisition, the Scheme, and proxies will be governed by English law and be subject to the exclusive jurisdiction of the courts of
APPENDIX 2
SOURCES OF FINANCIAL INFORMATION AND BASES OF CALCULATION USED IN THIS ANNOUNCEMENT
In this Announcement, unless otherwise stated, or the context otherwise requires, the following bases and sources have been used:
1. Financial information relating to Novae is extracted (without adjustment) from the audited consolidated financial statements for the
2. The value of the Acquisition is calculated on the basis of the fully diluted number of Novae Shares (at the price per Novae Share set out on page 1 of this Announcement) in issue referred to in paragraph 4 below.
3. As at the close of business on
4. The fully diluted share capital of Novae (being 66,795,621 Novae Shares) is calculated on the basis of 64,425,640 Novae Shares in issue on
5. The price per Novae Share set out on page 1 of this Announcement values the entire issued and to be issued ordinary share capital of Novae at approximately £467.6 million on the basis of a fully diluted share capital of 66,795,621 Novae Shares, assuming that all rights in respect of the vesting of awards under the Novae Share Schemes are exercised, or settled via alternative means, on the basis explained in paragraph 4 above.
6. The reported net tangible book value of Novae of £318.8 million referred to on pages 1 and 10 of this Announcement is extracted from the audited consolidated financial statements for the
7. The total managed capital amount of
8. The reference to the creation of a c.
9. Unless otherwise stated, all prices and closing prices for Novae Shares are closing middle market quotations derived from the daily official list of the
10. Certain of the figures included in this Announcement have been subject to rounding to the nearest decimal point or nearest two decimal points (as applicable).
11. Where the term “nominee” is used on pages 2, 12 and 13 of this Announcement, it shall not include
12. The exchange rates used for the conversion of Sterling amounts to US Dollar amounts (and vice versa) in this Announcement (where relevant) are: (i) a spot exchange rate of
APPENDIX 3
DETAILS OF IRREVOCABLE UNDERTAKINGS
The following holders or controllers of Novae Shares have given irrevocable undertakings to vote in favour of the Scheme at the Court Meeting and in favour of the resolution to be proposed at the General Meeting:
NOVAE DIRECTORS
| |
Number of Novae Shares |
Number of Novae Shares under Novae Share Schemes |
||
| |
968,972 | 428,246 | ||
| |
41,666 | - | ||
| |
23,952 | - | ||
| TOTAL | 1,034,590 | 428,246 | ||
AXIS has received irrevocable undertakings from the Novae Directors who hold Novae Shares in their own name or through a nominee in respect of all their own beneficial holdings of Novae Shares to cast (or procure the casting of) all voting rights attaching to such Novae Shares in favour of the Scheme at the Court Meeting and in favour of the resolution to be proposed at the General Meeting.
The irrevocable undertakings given by the Novae Directors will cease to be binding:
(a) if AXIS announces, with the consent of the Panel, that it does not intend to make or proceed with the Acquisition and no new, revised or replacement Scheme is announced by AXIS in accordance with Rule 2.7 of the Code at the same time;
(b) if the Scheme lapses or is withdrawn and no new, revised or replacement scheme of arrangement has been announced, in accordance with Rule 2.7 of the Code, in its place or is announced, in accordance with Rule 2.7 of the Code, within 10 Business Days of such lapsing or withdrawal;
(c) on the Longstop Date; or
(d) if any competing offer for the entire issued and to be issued share capital of Novae is declared wholly unconditional or, if proceeding by way of scheme of arrangement, becomes effective.
APPENDIX 4
DEFINITIONS
The following definitions apply throughout this Announcement unless the context otherwise requires:
| “Acquisition” | the proposed acquisition of the issued and to be issued share capital of Novae by AXIS (or, at AXIS’s election, a wholly-owned subsidiary of AXIS); | |
| “Announcement” | this announcement made pursuant to Rule 2.7 of the Code; | |
| “Articles” | the articles of association of Novae from time to time; | |
| “Authorisations” | has the meaning given in paragraph
4.1 of Part A of Appendix 1; |
|
| “AXIS” | |
|
| “ |
AXIS and its subsidiary undertakings excluding the Novae Group; | |
| “BMA” | the |
|
| “ |
the Novae Directors collectively; | |
| “Business Day” | any day (excluding any Saturday or Sunday or public or bank holiday) on which banks are open for business in London; | |
| “CMA” | the Competition and Markets Authority of the United Kingdom; | |
| “Code” | the City Code on Takeovers and Mergers; | |
| “Companies Act” | The Companies Act 2006; | |
| “Conditions” | the conditions to the implementation of the Acquisition (including the Scheme) as set out in Appendix 1 to this Announcement and to be set out in the Scheme Document; | |
| “Court” | the |
|
| “Court Meeting” | the meeting of Scheme Shareholders to be convened pursuant to an order of the Court pursuant to section 896 of the Companies Act, notice of which will be set out in the Scheme Document, for the purpose of considering and, if thought fit, approving the Scheme (with or without amendment) and any adjournment thereof; | |
| “CREST” | the relevant system (as defined in the |
|
| “Dealing Disclosure” | an announcement pursuant to Rule 8 of the Code containing details of dealings in interests in relevant securities of a party to an offer; | |
| “Disclosed” | has the meaning given in paragraph 4.2 of Part A of Appendix 1; | |
| “Disclosure and Transparency Rules” | the rules and regulations made by the |
|
| “Dormant Corporate Member” | each of |
|
| “Effective” | (i) if the Acquisition is implemented by way of the Scheme, means the Scheme having become effective pursuant to its terms; or
(ii) if the Acquisition is implemented by way of a Takeover Offer, means the Takeover Offer having been declared or become unconditional in all respects in accordance with the requirements of the Code; |
|
| “Effective Date” | the date upon which the Acquisition becomes Effective; | |
| “ |
the |
|
| “EFTA” | |
|
| “Evercore” | |
|
| “Excluded Shares” | (i) any Novae Shares beneficially owned by AXIS or any subsidiary undertaking (as defined in the Companies Act) of AXIS; and (ii) any Novae Shares held in treasury by Novae; | |
| “ |
the |
|
| “Forms of Proxy” | the forms of proxy in connection with each of the Court Meeting and the General Meeting which shall accompany the Scheme Document; | |
| “FSMA” | the Financial Services and Markets Act 2000 (as amended); | |
| “General Meeting” | the general meeting of Novae to be convened in connection with the Acquisition (and any adjournment thereof); | |
| “Listing Rules” | the rules and regulations made by the |
|
| “Lloyd’s” | the Society of Lloyd’s created by the Lloyd’s Acts 1871-1982, or any successor thereto; | |
| “ |
the |
|
| “Longstop Date” | means |
|
| “Market Abuse Regulation” | Regulation (EU) No. 596/2014 of the |
|
| “Novae” | |
|
| “Novae Deferred Bonus Plan” | the Novae Deferred Bonus Plan adopted by Novae in 2016, as amended from time to time; | |
| “Novae Directors” | the directors of Novae at the date of this Announcement or, where the context so requires, the directors of Novae from time to time; | |
| “ |
Novae, its subsidiaries, any holding company of Novae (intermediate or otherwise) and their subsidiary undertakings from time to time, or any of them, as the context requires; | |
| “Novae Long-Term Incentive Plans” | the Novae three-year Long-Term Incentive Plan adopted by Novae in 2007, as amended from time to time, and the Novae five-year Long-Term Incentive Plan adopted in 2017, as amended from time to time; | |
| “Novae Meetings” | the Court Meeting and the General Meeting; | |
| “Novae Senior Employee Share Plan” | the Novae Senior Employee Share Plan for senior employees of the |
|
| “Novae Share Based Bonus Schemes” | the Novae Deferred Bonus Plan for executive directors and senior employees of the |
|
| “Novae Share Incentive Plans” | the Share Incentive Plan adopted by Novae in 2017, as amended from time to time, together with the Share Incentive Plan adopted in 2007 and the legacy SVB Holdings Plc All Employee Share Ownership Plan; | |
| “Novae Shareholders” | holders of Novae Shares from time to time; | |
| “Novae Shares” | Novae ordinary shares of £1.125 each; | |
| “Novae Share Schemes” | the Novae Long-Term Incentive Plans, the Novae Senior Employee Share Plan, the Novae Share Based Bonus Schemes and the Novae Share Incentive Plans, each as amended from time to time; | |
| “Opening Position Disclosure” | as defined in the Code; | |
| “Overseas Shareholders” | Novae Shareholders who are resident outside the |
|
| “Panel” | the Panel on Takeovers and Mergers; | |
| “PRA” | the |
|
| “Regulation” | Council Regulation (EC) 139/2004; | |
| “Relevant Pension Plan” | has the meaning given in paragraph 3.11(d) of Part A of Appendix 1; | |
| “Restricted Jurisdiction” | any jurisdiction where local laws or regulations may result in a significant risk of civil, regulatory or criminal exposure if information concerning the Acquisition is sent or made available to Novae Shareholders in that jurisdiction; | |
| “ |
the |
|
| “Scheme” | the proposed scheme of arrangement under Part 26 of the Companies Act between Novae and the Scheme Shareholders, with or subject to any modification thereof or in addition thereto or condition approved or imposed by the Court and agreed by Novae with the approval of AXIS; | |
| “Scheme Court Hearing” | the hearing of the Court to sanction the Scheme under section 899 of the Companies Act; | |
| “Scheme Court Order” | the order of the court sanctioning the Scheme under section 899 of the Companies Act; | |
| “Scheme Document” | the circular to Novae Shareholders containing the terms of the Scheme, containing the explanatory statement required by section 897 of the Companies Act and convening the Court Meeting and the General Meeting; | |
| “Scheme Record Time” | the date and time to be specified in the Scheme Document, expected to be |
|
| “Scheme Shareholder” | a holder of Scheme Shares as appearing in the register of Novae at the Scheme Record Time; | |
| “Scheme Shares” | the Novae Shares:
(i) in issue at the date of the Scheme Document;
(ii) issued after the date of the Scheme Document but before the Voting Record Time; and
(iii) issued at or after the Voting Record Time and before the Scheme Record Time on terms that the original or any subsequent holders shall be, or shall have agreed in writing by such time to be, bound by the Scheme, in each case, excluding any Excluded Shares; |
|
| “Share Scheme Letter” | means the letter dated |
|
| “Special Resolution” | the special resolution to be proposed by Novae at the General Meeting in connection with, among other things, the approval of the Scheme and the alteration of the Articles and such other matters as may be necessary to implement the Scheme and the delisting of the Novae Shares; | |
| “Takeover Offer” | if (subject to the consent of the Panel and the terms of this Announcement) the Acquisition is effected by way of a takeover offer as defined in Part 28 of the Companies Act 2006, the offer to be made by or on behalf of AXIS to acquire the issued and to be issued ordinary share capital of Novae on the terms and subject to the conditions to be set out in the related offer document; | |
| “Third Party” | has the meaning given in paragraph 4.3 of Part A of Appendix 1; | |
| “ |
the |
|
| “ |
the |
|
| “US” or “ |
|
|
| “Voting Record Time” | the time and date specified in the Scheme Document by reference to which for entitlement to vote at the Court Meeting will be determined, expected to be |
|
Unless otherwise stated, all times referred to in this Announcement are references to the time in
All references to legislation in this Announcement are to the legislation of
Words importing the singular shall include the plural and vice versa, and words importing the masculine gender shall include the feminine or neutral gender.
A reference to “includes” shall mean “includes without limitation”, and references to “including” and any other similar term shall be interpreted accordingly.
For the purpose of this Announcement “subsidiary”, “subsidiary undertaking” and “undertaking” have the meanings given by the Companies Act.
References to “£”, “Sterling”, “GBP”, “p” and “pence” are to the lawful currency of the
References to “US dollar”, “USD”, “US$”, “$” or “cents” are to the lawful currency of
View source version on businesswire.com: http://www.businesswire.com/news/home/20170705006081/en/
or
Hugh Man, +44 20 7888 8888
or
or
Reeken Patel, Chief Financial Officer, +44 20 7050 9000
or
or
Source:


Global Specialty (Re)Insurer AXIS Capital Announces Acquisition of Novae
Adam Bergman – IRA Financial Group Partner – Authors Article on Application of Fiduciary Rules for Self-Directed IRA Private Fund Investors
Advisor News
- Election results cloud retirement legislation outlook, experts say
- Planning for the missing chapter
- Semi-retirement: helping clients balance flexibility with financial security
- The 6X Formula for leveraging content marketing with AI
- When a home becomes difficult to insure, the plan changes
More Advisor NewsAnnuity News
- Jackson Launches Direct-to-Consumer Annuity Offering
- Global Atlantic launches ForeIncome Flex
- Athene CEO criticizes offshore reinsurance, risk-taking by competitors
- DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
- John Hancock launches new fixed indexed annuity suite
More Annuity NewsHealth/Employee Benefits News
- Best’s Special Report: Rising Costs Could Offset AI-Driven Efficiency Gains at US Health Insurers
- Free Medicare counseling provided through LTADD
- Illinois consumers see higher prices and fewer choices for Obamacare health insurance
- COMPREHENSIVE REGULATIONS TO UNCOVER SUSPICIOUS HEALTHCARE (CRUSH) PROPOSED RULE (CMS-6098-P)
- CMS CRUSH PROPOSED RULE AIMS TO REAP NEARLY $90 BILLION FOR TAXPAYERS IN SAVINGS BY TARGETING FRAUD ACROSS MEDICARE, MEDICAID/CHIP, AND THE MARKETPLACE
More Health/Employee Benefits NewsLife Insurance News
- Navigating delayed death certificates: A guide for life insurance advisors
- Jackson Launches Direct-to-Consumer Annuity Offering
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Non-Life Insurance Segment
- AM Best Affirms Credit Ratings of Fubon Insurance Vietnam Co., Ltd.
- Three lawsuits put life insurers’ cost-of-insurance practices under scrutiny
More Life Insurance News